UNICHEM LABORATORIES LTD
UNICHEMLAB · General/Diversified · NSE
₹437
Current Market Price
Fair Value (DCF)
₹373
Discount to FV
-14.7%
Updated just now
YieldIQ Score
37/100
Piotroski F-Score
5/9
Economic Moat
None
Confidence
25%
ROE
5.6%
Debt/Equity
0.19
WACC
11.1%
Market Cap
₹3,080 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
10.3%
Return on capital employed
EV / EBITDA
11.1×
Enterprise multiple
Debt / EBITDA
2.0×
Leverage vs earnings
Interest Coverage
8.5×
EBIT covers interest
Current Ratio
2.05×
Short-term liquidity
Asset Turnover
0.59×
Revenue per ₹ of assets
Revenue CAGR (3Y)
19.1%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹437.4
Bear case
Discount -76.0%
Base case
Discount -17.2%
Bull case
Discount +15.8%
Ratio Trends
UNICHEMLAB · last 8 annual periods
ROE
5.6%
ROCE
10.3%
Operating Margin
—
Debt / Equity
0.19×
PE
25.6×
EV / EBITDA
—
Historical Financials
UNICHEMLAB · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1248 Cr | ₹1302 Cr | ₹1738 Cr | ₹2111 Cr | ₹2202 Cr | +15.3% |
| EBITDA | ₹118 Cr | ₹-46.7 Cr | ₹60.4 Cr | ₹300 Cr | ₹449 Cr | +39.6% |
| EBIT | ₹29.1 Cr | ₹-159 Cr | ₹-39.0 Cr | — | — | — |
| PAT | ₹33.1 Cr | ₹-202 Cr | ₹-93.8 Cr | ₹138 Cr | ₹253 Cr | +66.3% |
| EPS (diluted) | ₹4.68 | ₹-28.72 | ₹-10.01 | — | — | — |
| CFO | ₹-260 Cr | ₹-85.1 Cr | ₹14.0 Cr | ₹-7.0 Cr | ₹3.6 Cr | — |
| CapEx | ₹-127 Cr | ₹-44.3 Cr | ₹-22.6 Cr | ₹-137 Cr | ₹-123 Cr | — |
| FCF | ₹-387 Cr | ₹-129 Cr | ₹-8.6 Cr | ₹-144 Cr | ₹-119 Cr | — |
| Total Assets | ₹3319 Cr | ₹3193 Cr | ₹3275 Cr | ₹3569 Cr | ₹3737 Cr | +3.0% |
| Total Debt | ₹349 Cr | ₹314 Cr | ₹248 Cr | ₹460 Cr | ₹500 Cr | +9.4% |
| Shareholders' Equity | ₹2618 Cr | ₹2435 Cr | ₹2438 Cr | ₹2451 Cr | ₹2717 Cr | +0.9% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
UNICHEMLAB vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
SOLARA SOLARA | — | — | Pending | 0.0% | — |
 HIKAL HIKAL | — | — | Pending | -4.1% | — |
MOREPENLAB MOREPENLAB | — | — | Pending | 7.6% | — |
 IOLCP IOLCP | — | — | Pending | 7.7% | 15.5× |
BLISSGVS BLISSGVS | — | — | Pending | 10.8% | 17.7× |
Click a ticker to view its fair-value analysis.
Dividend History
6 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹8.00/sh
Last payout
2022-08-01
₹4.00
Peak payout
₹5.00
Trailing yield
—
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. UNICHEM LABORATORIES LTD (UNICHEMLAB.NS) trades at 437.40 vs a model fair value of 373.08, a gap of -14.7%. Piotroski F-score: 5/9. Moat ...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of UNICHEMLAB →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for UNICHEMLAB →
Compare
Head-to-head with peers
Compare UNICHEMLAB side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse UNICHEMLABNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.